Application study on catheterization to pseudoaneurysm of membranous ventricular septal defect with patent ductus arteriosus occlusion devices in children
10.3760/cma.j.issn.1673-4904.2011.06.001
- VernacularTitle:动脉导管未闭封堵器在儿童膜部瘤室间隔缺损介入治疗中的应用研究
- Author:
Yun XIANG
;
Pengfei DU
;
Shanzhi YANG
;
Xiaochen FAN
;
Ziping CHENG
- Publication Type:Journal Article
- Keywords:
Heart septal defects,ventricular;
Neoplasms;
Ductus arteriosus,patent;
Occluder device;
Transcatheter closure
- From:
Chinese Journal of Postgraduates of Medicine
2011;34(6):1-3
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study on transcatheter closure of membranous ventricular septal defect (VSD) with pseudoaneurysm by patent ductus arteriosus(PDA) occlusion devices in children and summarize the skill and clinical experience. Methods The study included 20 membranous VSD cases in children.According to the finding of the left ventricular angiography, various kinds of the PDA occlusion devices was implanted. The mean diameter of the waist of the occluder was ( 10.4 ± 2.6) mm. Examination by transthoracic echocardiography (TTE) immediately and left ventricular angiography after the occluder was implanted 15minutes later to evaluate the efficacy. Results In the 20 patients, one of the Ⅳ type VSD patient was quitted because of the significant residual shunts(≥2 mm). Slightly residual shunts ( ＜ 2 mm) was found in one Ⅲ type VSD patient with multi-outlet. And disappeared in 1 month after the procedure, which VSD patient was confirmed by TTE. Thirteen cases were normal by EKG examination (or the same before procedure).Incomplete right bundle branch block was found in 4 cases. First degree atrioventricular block was found in 1 case and paroxysmal junctional tachycardia was found in 1 case. All of them were recovered in 1 week.Conclusions Transcatheter interventional therapy with PDA occlusion devices for membranous VSD with pseudoaneurysm is safe and effective. The key of the procedure is to select suitable occluder and suitable position to plant them according to the membranous morphologic characteristics,size and position of the pseudoaneurysm. It is a facultative method for transcatheter therapy this kind of congenital heart disease.
